Published in Hepatitis Weekly, October 10th, 2005
This round was led by Lilly Ventures and included other new investors Medica Holdings, Adams Street Partners, Biogen Idec, Inc., Genentech, Inc., Partners Healthcare, and GC&H Investments. All of the company's original series A preferred stock investors, HealthCare Ventures, LLC, Morgenthaler Ventures, and Sequel Venture Partners also participated in the financing. In conjunction with their investment, Darren...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.